Patents by Inventor Hal T. Butler

Hal T. Butler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE DOSAGE FORMS OF FLUOXETINE AND ITS ENANTIOMERS
    Publication number: 20030013740
    Abstract: Chemically and physically stable pharmaceutical formulations, of the potent antidepressant, fluoxetine, its enantiomers and salts.
    Type: Application
    Filed: March 27, 1998
    Publication date: January 16, 2003
    Inventors: MARTIN P. REDMON, HAL T. BUTLER, STEPHEN A. WALD
  • Pharmaceutical compositions comprising norastemizole
    Publication number: 20020173522
    Abstract: The present invention relates to chemically stable pharmaceutical formulations of the potent antihistamine, norastemizole. The compositions can include norastemizole, or a pharmaceutically acceptable salt thereof; a diluent; a binder; a disintegrant; and a lubricant or the compositions can include particles of norastemizole, or a pharmaceutically acceptable salt thereof, coated with an inert coating and a pharmaceutically acceptable excipient. The present invention also relates to methods of treating allergic disorders.
    Type: Application
    Filed: February 15, 2002
    Publication date: November 21, 2002
    Inventors: Martin P. Redmon, Hal T. Butler, Stephen A. Wald
  • Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
    Publication number: 20020123504
    Abstract: Stable pharmaceutical compositions of descarboethoxyloratadine (DCL), a metabolic derivative of loratadine, for the treatment of allergic rhinitis and other histamine-induced disorders are disclosed. The compositions are formulated to avoid the incompatibility between DCL and reactive excipients such as lactose and other mono- and di-saccharides. Disclosed compositions include lactose-free, non-hygroscopic and anhydrous stable pharmaceutical compositions of DCL.
    Type: Application
    Filed: February 25, 2002
    Publication date: September 5, 2002
    Applicant: SEPRACOR INC.
    Inventors: Martin P. Redmon, Hal T. Butler, Stephen A. Wald, Paul D. Rubin